Examples of peptide compounds within WADAs regulatory framework are summarized in Tables 1 and 2, which distinguish between non-prohibited peptides and peptide hormones, growth factors, and related substances that are prohibited
Hanrahan JP, de Boer IH, Bakris GL et al (2021) Effects of the soluble guanylate cyclase stimulator praliciguat in diabetic kidney disease: a randomized placebo-controlled clinical trial
Additionally, only qualified healthcare professionals, such as physicians, nurse practitioners, or physician assistants, are authorized to administer these injections
exhibits high affinity binding hepatocyte growth factor (HGF) with a Kd of 65 pM
Statements Author contributions XD: Writing original draft
Side effects of Ozempic alternatives Because most Ozempic alternatives are GLP-1 receptor agonists that work similarly to Ozempic, they share many of the same side effects